Published on 11/01/2012
The Welsh government has said that it will pay to replace PIP implants for women who had them done privately.
Last week the UK government reaffirmed its view that the implants did not require routine removal. However, health minister for Wales Lesley Griffiths said that not replacing the PIP implants could put women at unnecessary risk.
Around 2,000 women in Wales are estimated to have the implants, but women must prove they sought redress from their private care provider and be a resident and registered with a GP in Wales to have them replaced.
On Tuesday Lesley Griffiths said: "We said then that we would replace implants which were put in by the NHS, and today we are going one step further by announcing we will also replace those which were put in privately.
"Removing the implants and not replacing them could result in unsightly scarring, loose skin, and potentially the accumulation of fluids, need for drainage, and risk of infection."
But Ms Griffiths stressed that NHS treatment would be a last resort for women who were treated privately, and safeguards would be put in place to hold the private sector to account.
This comes after a top surgeon urged for the removal of the 40,000 PIP breast implants estimated to be in the UK.
© ActiveQuote Health Ltd. 2012
Categories: Medical,
NHS and Hospitals
Related Health Insurance News Articles
16/04/2012Breast cancer sufferers in London to access Avastin on the NHSWomen in London with aggressive forms of breast cancer are to get NHS access to drug Avastin through a special cancer drugs fund set up by the government. Avastin is a tumour-starving drug that works by...
18/04/2012Watchdog NICE rejects breast cancer drug AvastinThe National Institute for Health and Clinical Excellence (NICE) has turned down drug Avastin for the treatment of breast cancer on the NHS. In draft guidance, NICE said it did not recommend Avastin...
24/04/2012Cancer patients missing out on effective treatment on the NHS Cancer patients may be missing out on the most effective treatments on the NHS because of poor access to new biomarker tests, according to a new survey. 100 oncologists took part in an online survey...
15/05/2012MRSA breeds in city hospitals and spreads to local hospitals by patient transferThe superbug MRSA spreads from large city hospitals to smaller local hospitals by patient transfer, according to a study published in the journal PNAS. MRSA is a type of bacterial infection that is resistant...
16/05/2012NHS patients wait for new drugs as NICE misses approval targetsNHS patients are waiting more than five years to receive new medicines because the National Institute for Health and Clinical Excellence (NICE) is missing its approval deadlines, according to a new study. ...